24/7 QualityMeds Blog – Access to Medicines & Healthcare Updates in India

Vitrakvi or larotrectinib is a kinase inhibitor indicated for the treatment of adult and pediatric patients with solid tumors that: have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment, especially for patients looking to buy larotrectinib online in India . Tropomysin receptor kinases (TRK) like TRKA, TRKB, and TRKC enable regulation in natural growth, differentiation, and survival of neurons when they interact with endogenous neutrotrophin ligands. These kinases are encoded by the NTRK1, NTRK2, and NTRK3 genes. Chromosomal rearrangements involving in-frame fusions of these genes with various partners, translocations in the TRK kinase domains, mutations in the TRK ligand-binding site, amplifications of NTRK, or the expression of TRK splice variants can resul...

Cablivi or caplacizumab-yhdp is a targeted antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It works by binding to the A1-domain of the von Willebrand factor (vWF), preventing its interaction with platelets which reduces abnormal platelet adhesion and consumption. It is used alongside plasma exchange and immunosuppressive therapy. The primary side effect of treatment with caplacizumab is hemorrhage as it increases the risk of potentially fatal bleeding, especially in those with underlying coagulopathies such as hemophilia or other coagulation factor deficiencies. Hence, concomitant use of antiplatelet agents or anticoagulants should be avoided. Monitoring and management of bleeding, if it occurs, is required   No information regarding the presence of caplacizumab in human milk, effects on children being breastfed or on milk production.  However, the condition of the mother, developmental and health benefits of breastfeeding as well...